Benefits of Pfizer, Moderna vaccines outweigh rare heart risks: WHO

File Picture

The benefits of mRNA COVID-19 vaccines outweigh the small risk that they may cause heart inflammation, as the jabs reduce hospitalisations and deaths, an advisory panel of the World Health Organisation said.

In a statement, the WHO said that reports of two rare conditions - myocarditis, an inflammation of the heart, and of its lining, called pericarditis - had typically occurred within days of vaccination, mainly among younger males after the second dose.

"Very rare cases of myocarditis and pericarditis have been observed following vaccination with the mRNA COVID-19 vaccines," it said, referring to the two vaccines using such technology, by Pfizer-BioNTech and Moderna.

"The benefits of mRNA COVID-19 vaccines outweigh the risks in reducing hospitalisations and deaths due to COVID-19 infections," it said.

Available data suggested myocarditis and pericarditis following vaccination was "generally mild" and responded to treatment such as rest or non-steroidal anti-inflammatory drugs, the WHO said. "Follow-up is ongoing to determine long-term outcomes," it said.

"Vaccinated individuals should be instructed to seek immediate medical attention if they develop symptoms indicative of myocarditis or pericarditis such as new onset and persisting chest pain, shortness of breath, or palpitations following vaccination," it added.

Earlier on Friday, Europe's drug regulator said it had found a possible link between very rare heart inflammation and COVID-19 vaccines from Pfizer-BioNTech and Moderna. It too stressed that the benefits of the shots outweighed any risks. 

More from International

Coming Up on Dubai Eye

  • The Business Breakfast

    6:00am - 11:00am

    The Business Breakfast is the day’s must listen for the UAE’s business leaders, and those who aspire to be.

  • Lunch with Lloyd

    11:00am - 2:00pm

    No one knows entertainment better than veteran Dubai broadcaster Mark Lloyd.

BUSINESS BREAKFAST LATEST

  • Green Financing

    HSBC has announced $5 billion in growth lending initiatives, part of it will be dedicated to green incentives.

  • Health Travel Pass

    How do you feel about a health travel pass that records your COVID information ahead of travel?

  • Retail in Times of E-commerce

    How are retail giants like Majid Al Futtaim competing against behemoths of e-commerce like Amazon?

On Dubai Eye